Scorpius Biomanufacturing is a U.S.-based CDMO that provides cGMP manufacturing and bioanalytical services for mammalian and microbial biologics, focusing on small-volume programs for emerging biotechs and academic researchers. The company addresses the need for reliable and efficient biomanufacturing capacity in the U.S. by offering integrated process development and analytical expertise to accelerate the path to market for biologics.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Emerging biotech companies and academic researchers often face challenges in securing reliable and efficient biomanufacturing capacity, particularly for small-volume programs. The lack of integrated process development and analytical expertise can further delay the path to market for novel biologics.
Solution
Scorpius Biomanufacturing is a CDMO that provides cGMP manufacturing, bioanalytical testing, and process development services for protein modalities. The company specializes in mammalian and microbial biologics, offering services from pre-clinical evaluation to clinical and commercial manufacturing. By integrating analytical methods development, process development, cGMP manufacturing, product characterization, and QC release testing, Scorpius enables a faster path to clinical trials and product commercialization. The company's facility features cleanrooms for mammalian cell culture and harvest, downstream purification, formulation, and fill-finish.
Target Audience
The primary customers are emerging biotechs, academic researchers, and government institutions requiring biomanufacturing, bioanalytical, and process development services for protein modalities.
Features
- cGMP manufacturing for mammalian and microbial biologics
- Process development for mammalian cell culture, microbial fermentation, and cell therapy products
- Analytical methods development, qualification, and validation
- Comprehensive analytical testing services for product characterization and release
- Stability testing programs conducted under ICH guidelines
- Upstream and downstream processing up to 500 L scale for mammalian and cell-therapy based products
- Up to 200 L scale for microbial-based products
- cGMP-compliant cleanroom manufacturing space